You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窩輪》【瑞通認股證牛熊證】恆指日升日跌、即市資金好淡分歧 投資者博美團彈恆指牛51873 熊52153/ 美團牛58875 熊56687/ 建行購18177
阿思達克 03-04 10:20
市場觀望美國新一輪刺激經濟方案的進展,但債息回升,拖累美股表現。道指隔晚收報31270點,跌121點(或0.39%);納指下挫2.7%。恆指昨收報29880點,升784點(或2.7%),盤中高見29912點。今早最多挫逾400點,回至29500點以下。恆指好倉(牛證及認購權證)昨淨流出逾1.8億港元(下同),恆指淡倉(熊證及認沽權證)同日淨流入逾2.1億元,反映投資者看淡恆指後市走勢。昨日恆指牛證街貨重貨區為收回價27800至27899點,而熊證街貨重貨區為收回價30300至30399點。

美團(03690)旗下社區團購業務美團優選,因涉不正當價格行為遭市場監管總局行政處罰150萬人民幣,美團優選回應稱高度重視誠懇接受,加強整改。美團昨一度逆市挫2.6%,低見352.8元,險守50天線,午後轉升,收報372.6元,升2.82%。股份今早曾回吐逾4%,下試350元關口。昨有逾1.9億元北水淨沽出美團。輪證資金流方面,逾4100萬元淨流入其好倉,淡倉同日則有約810萬元淨流出。

官方媒體刊登文章引述分析人士稱,預計3月資金面將繼續以穩為主,定向降準可能適時落地。另有券商看好內銀業今年盈利增長速度可創5年高,有序出清問題資產也有利行業估值修復。內銀股昨集體炒上,建行(00939)以全日高位6.4元收市,抽升5.6%,一舉重越10天和20天線,並結束三連跌走勢。建行今早曾跌逾2%,跌穿6.3元,曾考驗10天線(6.25元)的支持力。上日有逾3.3億元北水淨買入建行。輪證資金流方面,近580萬元淨流出其好倉,淡倉同日則有約80萬元淨流入。

微盟(02013)昨曾低見22.2元,下瀉8.6%,收市維持3.5%跌幅,報23.45元,為昨日表現第二差科指成份股。微盟今早跌勢未止,曾跌逾7%,失守22元,連跌三日。昨有逾300萬元淨流入其好倉,淡倉同日則有小量資金淨流出。

有券商料恆指改革後新經濟股佔比升至逾52%,贏家包括科技、消費及醫藥股,平安好醫生(01833)是其中一隻被市場視為日後有機會染藍的股份。平安好醫生昨逆市跌近1%收市,報111.6元,今早再挫約4%,曾跌穿107元,暫錄三連跌。上日其好倉有逾390萬元淨流入,淡倉同日亦有小量資金淨流入。

瑞通相關認股證之選擇:

美團價外、短期購20119,行使價:419元,2021年5月到期,實際槓桿:6倍

美團價外、短期沽18034,行使價:264.88元,2021年6月到期,實際槓桿:6.6倍

建行輕微價外、中短期購18177,行使價:6.78元,2021年8月到期,實際槓桿:7.8倍

微盟價外、中短期購21478,行使價:26.88元,2021年8月到期,實際槓桿:2.3倍

平醫價內、中短期購21295,行使價:100.98元,2021年6月到期,實際槓桿:5倍

港交輕微價外、中短期購29628,行使價:531.88元,2021年7月到期,實際槓桿:6.2倍

港交輕微價外、中短期沽12738,行使價:448.68元,2021年7月到期,實際槓桿:6.1倍

工行輕微價外、中年期購20878,行使價:5.88元,2021年10月到期,實際槓桿:6.4倍

瑞通相關牛熊證之選擇:

恆指牛證51873,收回價:28860點,槓桿比率:52.7倍

恆指熊證52153,收回價:29940點,槓桿比率:35.5倍

美團牛證58875,收回價:316.88元,槓桿比率:8.4倍

美團熊證56687,收回價:398.88元,槓桿比率:7倍

建行牛證66891,收回價:5.72元,槓桿比率:8.8倍

建行熊證55545,收回價:7.08元,槓桿比率:7倍

微盟牛證58929,收回價:20.01元,槓桿比率:7.7倍

微盟熊證59974,收回價:35.5元,槓桿比率:1.5倍

平醫牛證65016,收回價:96元,槓桿比率:6.4倍

平醫熊證55687,收回價:134元,槓桿比率:3.3倍

港交牛證52168,收回價:459.599元,槓桿比率:19.3倍

港交熊證56679,收回價:546.88元,槓桿比率:6.5倍

工行牛證55707,收回價:4.92元,槓桿比率:10倍

工行熊證54632,收回價:5.5元,槓桿比率:12.3倍

重要風險通知

本結構性產品並無抵押品。

結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。

閣下投資前應了解產品風險,如有需要應諮詢專業建議。~

重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account